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Recent studies in both human and murine systems have suggested that natural 
killer (NK) t activity can  be mediated by different populations of effector cells 
(1-3).  In  human  peripheral  blood,  most  NK cells were found in  the  null  cell 
fraction (4) and were morphologically identified as large granular  lymphocytes 
(LGL) (5).  When analyzed with monoclonal antibodies directed at well-defined 
surface structures, purified LGL were shown to be a heterogeneous population 
of cells, probably containing  various subsets.  For example,  30%  of LGL react 
with anti-T8,  70-80%  with anti-T11  and/or anti-Mol,  and 40-50%  with anti- 
T 10 (6-8). In addition, many studies have demonstrated that not only LGL but 
also activated T  lymphocytes were able to mediate  NK or NK-like activity (9- 
11). 
To  both  dissect  the  heterogeneity  of NK  cells  and  subsequently  perform 
studies with homogeneous populations of these cytotoxic lymphocytes, we have 
recently developed human  NK clones (7).  This approach was made possible by 
previous studies which demonstrated that NK cells can be cultured and expanded 
in conditioned  medium containing  interleukin  2 (IL-2), and that  cultured cells 
maintain stable phenotype and functional activity for prolonged periods of time 
in vitro (12,  13).  Furthermore,  when a series of human NK clones was analyzed 
with monoclonal antibodies, their phenotypic heterogeneity confirmed previous 
observations  made  with  uncloned  populations  of cells  (14).  Three  groups  of 
clones could be distinguished by analysis of cell surface markers. One group was 
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shown  to  phenotypically represent  mature  T  lymphocytes.  A  second  group, 
derived from purified LGL, expressed distinct combinations of T  lymphocyte- 
associated surface structures but lacked the mature T  cell differentiation antigen 
T3. Finally, one clone did not express any T  cell markers or any other lineage- 
related  differentiation  antigens.  Although  NK  clones  were  obtained  using  a 
variety of initial triggering stimuli for proliferation, they were all selected on the 
basis of the same functional criteria, i.e., the capacity to lyse K562 cells that are 
used as a  standard  target  in  NK assays.  In  addition,  when  these clones  were 
tested in cytotoxicity assays against a panel of established cell lines, it was found 
that these cional populations of iymphocytes had distinct target specificity (14). 
Taken together, these results suggested that what is usually referred to as NK 
or NK-like activity (i.e., the ability to kill K562 cells without apparent presensi- 
tization in vitro) is mediated by populations of lymphocytes that have distinct 
phenotypes and functional repertoires. 
The present studies are directed at identifying the structural basis of effector/ 
target cell interaction  for individual human  NK clones.  This report  describes 
experiments performed with two N K cloned cell lines termed JT9 (14) and JT 10 
(8),  which were both  independently derived from phytohemagglutinin (PHA)- 
stimulated lymphocytes of a single donor and selected initially for their ability to 
kill  K562  cells.  Through  the  generation  of a  monoclonal antibody produced 
against JT9, it was found that both JT9 and JT 10 cells, which have a mature T 
lymphocyte phenotype (T 1  +T3+T8+T 11 ÷T 12+), express a 90 kD heterodimeric 
structure.  This  structure,  termed  NKTa,  is  linked  to  the  T3  molecule  and 
appears  to  be  analogous  to  Ti  cionotypic  determinants  (15)  that  have  been 
identified on specific ailoreactive cytotoxic T  lymphocytes (CTL).  Our studies 
suggest that the  NKTa  molecule present  on JT9  and JT10  cells is intimately 
involved in determining the target specificity of these two NK active clones. 
Materials and Methods 
Isolation of Subpopulations of Peripheral Blood Cells.  Human peripheral blood mononu- 
clear cells (PBMC) were isolated from healthy volunteer donors by Ficoll-Hypaque (F/H) 
density gradient centrifugation. Monocyte-enriched adherent cells were obtained from 
PBMC by two-step adherence on plastic culture dishes.  Granulocytes were isolated from 
F/H gradient pellets using high molecular weight dextran (8). Activated T  cells were 
generated by stimulating PBMC with either PHA (2 ~g/ml), allogeneic Epstein-Barr virus 
(EBV)-transformed B cells (Laz 388), or autologous EBV-transformed B cells (Laz 401) at 
a  1  : 1 stimulator/responder ratio. They were tested on day 6 after stimulation. 
Previously Characterized Monoclonal Antibodies.  Monoclonal antibodies  used  in  these 
studies have been previously described in detail. T 1 and T 12 antigens are expressed on a 
fraction of thymocytes and on the vast majority of peripheral blood T cells (16). Anti-T3 
defines all mature T lymphocytes in human peripheral blood (17). T8 antigen is expressed 
on a  subset of peripheral  T  cells having primarily cytotoxic/suppressor function (18). 
Functional properties of anti-T8A.B.c have been previously described in detail (19). Anti- 
T 11 defines an antigen associated with the sheep erythrocyte receptor (16). In peripheral 
blood, 901  antigen is expressed on  ~7%  of cells that morphologically appear to be a 
homogeneous population of LGL. >95%  of NK activity in peripheral blood is found 
within the purified 901 + fraction. Anti-901  antibody was found to be reactive with 1% of 
T3 + cells by fluorescence microscopy but does not react with monocytes, granuiocytes, B 
cells, erythrocytes, or platelets (8). 
Generation of Human  Cloned Cell Lines.  Methods for generation of human NK cloned HERCEND  ET  AL.  1549 
cell lines and aliogeneic CTL clones have been described in detail (7,  14). Briefly, clones 
were obtained using a limiting dilution technique.  Either PBMC or LGL were cloned at 
one cell per well on a feeder layer ofautologous, irradiated (5,000 tad) PBMC plus either 
PHA (2 #g/ml) or allogeneic or autologous, irradiated (5,000  rad) EBV-transformed B 
cells.  Selected  colonies  were expanded  by the  addition  of culture  medium  containing 
lymphocyte-conditioned  medium  (LCM)  (10-15%  final  dilution)  every  3  d.  Culture 
medium  was  RPMI  1640  supplemented  with  1%  penicillin-streptomycin,  1%  sodium 
pyruvate,  and  20%  human  AB  serum.  All  cell  lines  used  in  these  studies  have been 
subcloned  at  least  four  times  at  100  cells  per  well  on  a  feeder  layer  of autologous, 
irradiated PBMC plus irradiated EBV-transformed B cells. After subcloning procedures, 
both phenotype and cytotoxic function have remained stable. 
Preparation  of LCM Containing IL-2.  LCM was produced by stimulating whole PBMC 
at a concentration of 2.5  X  10b/mi for 2 h  with 5 #g/ml PHA (Burroughs Wellcome & 
Co., Greenville, NC), 5 ng/ml phorbol myristate acetate (Sigma Chemical Co., St.  Louis, 
MO), and 5,000 rad-irradiated Laz 388 (0.5 ×  106/ml). The cells were then washed four 
times to remove the mitogens and were resuspended in RPMI  1640 supplemented with 
2.5%  human  AB  serum.  After  40  h  of incubation  at  37°C,  the  supernatants  were 
harvested, passed through 0.45 #m filters, and stored at -70°C. 
Production of the Anti-NKTa Antibody.  6-wk-old female BALB/c mice were immunized 
with JT9 cells. The immunization schedule consisted of an initial intraperitoneal injection 
of 2  x  106  cells  emulsified  in  complete  Freund's  adjuvant  (Difco  Laboratories,  Inc., 
Detroit, MI) followed by two weekly intraperitoneal injections of 2 X  106 viable cells in 
phosphate-buffered saline (PBS).  2  wk later,  2  X  106 cells were injected intravenously, 
followed by splenectomy 3  d  later.  Somatic cell  hybridization  was carried  out  by the 
method of Kohler and Milstein (20). 
Cell Lines.  Several continuously growing cell lines were used in these studies. Laz 461, 
Laz 156, and Laz 388 are EBV-transformed lymphoblastoid B cell lines. Nalm-1 and Laz 
221 are common acute lymphoblastic leukemia antigen (CALLA)-positive acute lympho- 
cytic leukemia cell lines.  Daudi  was derived from a  Burkitt's lymphoma. Molt-4, CEM, 
HPB ALL, JM,  and  HSB are T  cell leukemia cell  lines.  K562  was established from a 
patient with chronic myelogenous leukemia and HL60 from a patient with acute promye- 
locytic leukemia. U937 is a histiocytic cell line. 
Cytotoxicity Assays.  To  investigate  the  functional  effects  of monoclonal  antibodies, 
cloned cells were incubated for 18 h  with antibodies or medium before the addition of 
5tCr-labeled targets. Cytotoxic activity of the clones was tested in 4-h assays.  All experi- 
ments were performed in  triplicate using V-bottomed microtiter plates according to a 
standard  method previously described (8,  14).  Medium for cytotoxic assays was RPMI 
1640  plus 20%  human  AB pooled serum and  1%  penicillin-streptomycin. Assays were 
performed at a  10:1 effector/target (E/T) ratio using 4,000 target cells per well. 
Proliferative Studies.  To investigate the effects of monoclonal antibody treatment on 
their proliferative capacity, 25,000 cloned cells were incubated for 24 h with saturating 
amounts  of LCM  containing  IL-2  and/or  saturating  amounts  of antibody  in  round- 
bottomed microtiter plates (Costar, Cambridge, MA). Experiments were done in culture 
medium. Cultures were then pulsed for 12-18 h with 0.2 #Ci of tritiated thymidine and 
subsequently harvested on a MASH II apparatus (Microbiological Associates, Walkersville, 
MD). Tritiated thymidine incorporation was measured using a liquid scintillation counter 
(Packard Instrument Co., Downers Grove, IL). 
Modulation  of Surface Antigens by Monoclonal Antibodies.  Cloned cells at 1 ×  106/mi were 
incubated with saturating amounts of one or another monoclonal antibody for 36 h  at 
37°C in final culture media. Control cells were cultured in media alone. Subsequently, 
the cells were washed three times and analyzed for expression of cell surface antigens by 
means of indirect immunofluorescence assays performed at 4°C. 
Phenotypic  Analysis  of Cell  Surface  Antigens.  Phenotypic  analysis  was  performed  by 
indirect  immunofluorescence with  fluorescein-conjugated  goat anti-mouse  Fab  IgG as 
described previously (7).  Samples were analyzed on an Epics V flow cytometer (Coulter 
Electronics,  Hialeah,  FL).  10,000  cells  were analyzed in  each  sample.  Each  histogram 1550  ANTIBODY  BLOCKING  NATURAL  KILLING 
displays  the  number  of cells  (ordinate) versus  the  intensity of fluorescence (abscissa) 
expressed on a  logarithmic scale. The negative control used to determine background 
fluorescence was an ascites derived from a nonreactive hybridoma. Monoclonal antibodies 
were always used at saturating concentrations (1:100-1:500). 
su~IcS~ar~e~e~abelt~n~n(d~wnEngpjC~p~qatu~OlnaOrf  ' ~t~gen~ f~lA)JT9ngellsLindarC~l~tw;re 
oxidase method previously described (15). 2 x  107 viable, proliferating cells were washed 
with RPMI  1640,  resuspended in PBS, and labeled with 1 /zCi ~2sI for 15 min at room 
temperature, followed by the addition of 100 #1 NaI (1 mol/iiter). Labeled cells were then 
harvested and  washed  three  times  in  cold  RPMI  1640.  Cell  lysate was  prepared  by 
resuspending the cell pellet in 300 ~l RIPA buffer, pH 7.5, containing 1% Triton X-100, 
0.15  M  NaC1, 0.01  M  NaH~PO4,  1 mM  EDTA,  1  mM  EGTA,  1 mM  NaF,  1 mM 
phenylmethylsulfonyl  fluoride, and trypsin inhibitor and agitated for 40 rain at 4°C. Cell 
lysates were stored at -70°C before use. 
Immune precipitations were carried out using preformed complexes of rabbit anti- 
mouse Ig and specific monoclonal antibody as described previously (21). Briefly, macro- 
molecular aggregates were removed from cell lysate by ultracentrifugation for 30 min at 
100,000 g. Cell lysates were then precleared three times by incubation at 4°C for 1 h with 
either formalin-fixed Staphylococcus  aureus bacteria and/or preformed complexes of rabbit 
anti-mouse Ig and nonspecific monoclonal antibody. Aliquots of precleared lysate were 
then incubated with specific preformed complexes for 2 h at 4°C. Immune precipitates 
were then washed four times with RIPA buffer as above and then dissolved in sodium 
dodecyl suifate-polyacrylamide  gel electrophoresis (SDS-PAGE) sample buffer and loaded 
onto  separate  slots  on  a  10%  polyacrylamide slab  gel.  Identical aliquots  of immune 
precipitates  were  run  in  reduced  and  nonreduced  conditions.  Gels  were  dried  and 
radiolabeled precipitates were visualized using standard methods (22). 
Results 
Generation of a Monoclonal Antibody Blocking Cytotoxic Activity of  JT9 Cells.  After 
immunization of mice with JT9 cells,  1,250 hybridoma colonies were produced 
in a  series of five fusion experiments.  Hybridoma supernatants were primarily 
screened for their ability to block the cytotoxicity of theJT9 clone towards K562 
cells. For this purpose, constant numbers of cloned cells were incubated overnight 
with individual supernatants, and cytotoxic activity was subsequently measured 
using 5XCr-labeled K562 targets. One hybridoma that totally blocked cytotoxicity 
of JT9  cells was selected for further studies.  It was recloned twice by limiting 
dilution and immune ascites was produced.  This monoclonal antibody (termed 
anti-NKTa) was of the IgG1 subclass as determined by Ouchterlony immunopre- 
cipitation using standard reagents. Its activity was then retested under the same 
experimental conditions used for the initial screening. Anti-T 11  and anti-T12, 
previously shown to be both reactive with JT9  cells and unable to block their 
cytotoxic function, were  used as negative controls.  Results presented in Fig.  1 
are representative of five individual experiments and show that anti-NKTa totally 
abrogated the cytotoxicity of the clone. Blocking of cytotoxicity was concentra- 
tion dependent and the optimal blocking effect was reached at a  10 -3 dilution of 
the ascites.  This dilution was then used in  subsequent assays. Viability of IT9 
cells as determined by trypan blue dye exclusion was not affected by incubation 
with anti-NKTa ascites at any dilution. 
JT9 cells were previously shown to proliferate in LCM containing IL-2 (14). 
This proliferative response was tested in the presence of the anti-NKTa antibody 
in order to exclude the possibility that the inhibition of cytotoxicity produced by HERCEND  ET  AL.  1551 
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FIGURE  1.  Inhibition  of the  cytotoxicity  of JT9  cells towards  K562  cells  by  anti-NKTa 
monoclonal antibody. Mean +  SD _~ 5% for each point; E/T ratio,  10:1. 
TABLE  I 
Influence of Monodonal Antibodies on Proliferative Response of  JT9 Cells to IL-2 
Untreated  Anti-T8^  Anti-T3  Anti-NKTa 
Medium  72 -+ 26*  56 _  6  45 _+ 22  288 +  42 
IL-2*  1,320 _+ 93  1,245 +  21  4,034 _+ 262  4,826 -  348 
* Results are expressed as mean counts per minute for triplicate cultures _  SD. 
* LCM containing IL-2. 
this  reagent could be attributed  to a  general decrease in  the function of the 
cloned cells.  The  influence of anti-T3  and anti-T8A antibodies  was  tested in 
parallel. JT9 cells were cultured for 36 h with saturating concentrations of each 
monoclonal antibody in the presence of IL-2. [3H]thymidine incorporation was 
measured during the last  12 h  of culture.  It was found that both anti°T3 and 
anti-NKTa strongly increased the proliferative response of the clone to  IL-2, 
whereas anti-TSA had no effect (Table I). 
Cellular  Distribution  of the  NKTa  Antigen.  The  reactivity of the anti-NKTa 
antibody was tested on purified subpopulations of lymphoid and nonlymphoid 
cells by  indirect  immunofluorescence assay and  subsequent analysis  using an 
Epics  V.  As  shown  in  Table  II A,  all  the cellular populations  studied,  either 
autologous to JT9 or derived from other donors, were found to be negative. In 
addition, a series of in vitro established cell lines, including those used as targets 
in  cytotoxicity assays,  were shown to  be  unreactive with anti-NKTa antibody 
(Table II B), The expression of the NKTa antigen was subsequently investigated 
using  several  cloned  cell  lines  displaying  distinct  phenotypes  and  cytotoxic 
functions (Table II C). JT1 and JT3, previously described NK clones (14), were 
negative, as were JT12,  13, and  14,  which are three specific alloreactive CTL 
clones derived from the same donor and directed to the EBV-transformed cell 
line Laz 388.  Five additional and well-characterized CTL clones, including the 
CT8I, line (15) derived from a different donor, were also found to be unreactive 
(data not shown). 
In contrast,  one NK  cloned cell line (in addition  to JT9)  termed JT10  did 
express the NKTa antigen.JT10 was obtained in cloning experiments performed 
6 mo after those in which JT9 was produced. Samples of the initial clone were 
frozen away immediately after screening procedures, and the presence of the 1552  ANTIBODY  BLOCKING  NATURAL  KILLING 
TABLE  II 
Screening  for Reactivity of the Anti-NKTa Antibody 
A.  Cell fractions* 
Autologous cells  *0  Allogeneic cells 
Peripheral blood mononuclear cells (3) ! 
Monocytes (3) 
Granulocytes (3) 
Red cells (2) 
PHA-activated T  cells (3) 
Peripheral blood mononuclear cells 
Monocytes 
Granulocytes 
Red cells 
PHA-activated T  cells, 
AIIoreactive T  cells 
Autoreactive T  cells  ~  Thymocytes (2) 
B.  In vitro established tumor- or viral-transformed cell lines  *0 
B cells: Laz 221, Nalm-l, Daudi, Laz 388, Laz 156 
T  cells: Molt-4, CEM, HSB, HPB-ALL, JM 
Nonlymphoid cells: K562, KG-1, U937, HL60 
C.  Cloned cytotoxic cell lines  0 
Phenotype  Function  NKTa reactivity 
JT 1  T3-T4-T8-T 11-901 ÷  NK  --* 
JT3  T3-T4-T8-T 11÷901 ÷  N K  -- 
JT9  T3÷T4-T8+T 11 +901 ÷  N K  >95 
JT 10  T3+T4-T8+T 11 +901 +  NK  >95 
JT12  T3÷T4-T8+T11÷901 -  CTL  -- 
JT 13  T3+T4-T8+T 11 +901-  CTL  -- 
JT14  T3+T4-TS+T 11÷901 -  CTL  -- 
* Number of positive cells was <4% in each determination unless otherwise mentioned. 
* Cells autologous to JT9. 
0 Two or more determinations per cell fraction or cell line. 
I Number of individuals tested. 
Autologous T  cells stimulated by autologous EBV-transformed B cells. 
NKTa antigen was found on both initially frozen cells and on those maintained 
in  long-term  cultures.  The  origin  of JT10  is  similar  to that  of JT9  since it  is 
derived from PBMC (of the same individual) initially stimulated by PHA. The 
two clones have  identical  phenotypes  when  assessed using anti-T1,  -T3,  -T4, 
-T8, -T 11, -T 12, and -901 antibodies. 
Evidence for Comodulation  of NKTa and T3 Structures.  A  series of experiments 
was performed to assess whether anti-NKTa antibody would induce modulation 
of its target antigen. JT9 cells were cultured for 24 h at 37°C in the presence of 
a  saturating  concentration  of anti-NKTa.  Cells were subsequently washed and 
analyzed  for  expression  of NKTa,  T3,  T8,  T11,  and  T12  antigens  using  an 
indirect immunofluorescence assay at 4°C. As shown in Fig. 2, it was found that 
anti-NKTa antibody was able to induce modulation of its own target structure. 
In  addition,  incubation  with  anti-NKTa  at  37°C  resulted  in  the  simultaneous 
decrease in expression  of the surface T3  molecule.  In contrast,  the expression 
of T8 antigen  was not modified.  Other surface antigens such as T11  and T12 
were also not affected when  modulation  was induced  by anti-NKTa  antibody 
(data  not  shown).  Reciprocal  experiments  were conducted  in  which JT9  cells 
were incubated with anti-T3 for 24 h. When cells were reanalyzed, it was found 
that  as a  result  of the  modulation  induced  by anti-T3  (16),  the  expression  of 
both T3 and NKTa antigen  was markedly decreased whereas expression of T8 HERCEND ET  AL.  1553 
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FIGURE 2.  Coimodulation  of  T3 and NKTa antigen.  JT9 cells were divided into three groups 
(vertical  axis) and incubated for 24 h with medium (unmodulated), anti-T3, or with anti-NKTa 
antibody. After this period of culture, cells from each  group were  washed three  times and 
retested  at  4°C  for  expression  of T3,  T8,  and  NKTa  antigens  (horizontal  axis)  using an 
indirect immunofluorescence assay.  Each population was then analyzed using an Epics V flow 
cytometer. Anti-T6 antibody was used as a negative control (NEG) in these experiments. 
TABLE III 
lnfluence of Anti-T3, Anti-NKTa, and Anti-T8 Antibodies on Cytotoxic Activity of  JT9 Cells 
Target cells 
Preincuba- 
tion  K562  KG-1 U937 Daudi  Laz  HPB  JM  CEM  221  Nalm-I Molt-4 HSB  ALL 
Medium  70*  79  44  85  61  75  76  62  58  76  62 
Anti-T3  20  11  6  2  4  I0  14  37  4  33  10 
Anti-NKTa  12  13  2  1  2  2  2  25  2  8  8 
Anti-T8A  59  92  51  91  65  99  76  80  53  76  63 
* Percent specific cytotoxicity,  SD ~ 5%; E/T ratio, 10: I. 
antigen was not affected (Fig. 2). 
Influence  of Anti-NKTa,  T3,  and  T8 Antibodies  on  the  Cytotoxicity of JT9  Cells 
Towards  a Panel of Sensitive  Targets.  It  has been previously demonstrated that 
the JT9 clone, although initially selected for its ability to kill K562 cells, is also 
cytotoxic for a  variety of unrelated tumor cells (14).  The blocking capacity of 
anti-NKTa, -T3,  and -T8  antibodies could therefore be assessed using a  large 
panel of sensitive target cell lines. As shown in Table III, after 18 h of preincu- 
bation with either anti-NKTa or anti-T3,  the cytotoxicity of JT9 cells towards 
all targets tested was strongly decreased. In contrast, anti-T8A, which blocks the 
cytotoxicity of T8 ÷ alloreactive T  cell  clones (19),  did not influence the  lytic 
capacity of JT9  cells against any target.  Anti-T8B, anti-T8c, and an additional 
anti-T8  antibody obtained after immunization with JT9  cells were also tested 
using a  more restricted panel of target cells. None of these anti-T8 antibodies 
were able to block the cytotoxic function of  JT9 cells (data not shown). Additional 
control experiments not included in Table III indicated that anti-NKTa was not 
able to block cytotoxicity of either NK or CTL clones found to be unreactive 
with the antibody in immunofluorescence assays. 
hnmunoprecipitation  of 125I-labeled NKTa Antigen.  Immunoprecipitation exper- 
iments using preformed complexes of rabbit anti-mouse IgG and NKTa antibody 
and 125I surface-labeledJT9 cell lysates were performed as described in Materials 
and  Methods.  As  shown  in  Fig.  3,  anti-NKTa  precipitated  two  bands  with 
molecular masses of approximately 49,000 and 43,000  daitons under reducing 
conditions in SDS-PAGE.  Under nonreducing conditions, this antigen appears 1554  ANTIBODY BLOCKING NATURAL KILLING 
FIGURE 3.  Immunoprecipitation  of NKTa antigen from 1251 surface-labeled  JT9 cells. Im- 
munoprecipitation of 125I-labeled  JT9 cells was resolved by SDS-PAGE using 10% polyacryl- 
amide gels as described in Materials and Methods, under both reduced and nonreduced 
conditions. Radiolabeled standards of various molecular weights were run in parallel with 
immunoprecipitates as follows: (A) anti-NKTa, nonreduced, (B) negative control complex 
(anti-MY4), nonreduced, (C) negative control complex (anti-MY4), reduced, (D) anti-NKTa, 
reduced. 
as a  single band corresponding to a  molecular mass of 90  kD.  Similar results 
were obtained using [35S]cysteine metabolically labeledJT9 cells (data not shown). 
Identical Reactivity of JT9 and JTIO Cells Towards a Panel  of Randomly Selected 
Target Cells.  Immunoprecipitation experiments indicated that anti-NKTa anti- 
body was  directed at a  heterodimer of similar molecular weight as that of Ti 
clonotypic determinants recently identified on specific CTL clones (I 5, 23). Since 
anti-Ti antibodies blocked antigen-specific proliferation of CTL clones as well as 
cytotoxicity against antigen-bearing target cells (15,  23), it has been postulated 
that  Ti  determinants were  likely to  represent  antigen-receptor structures  on 
specific T  lymphocytes. The role of NKTa molecules present on JT9 and JT10 
cells was analyzed in light of these previous results. Since it has been established 
that in humans, individual NK clones can have different repertoires for target 
cell recognition and/or lysis (14),  it was of particular interest to assess whether 
two independently derived NK clones that were found to express the same 90 
kD clonotype would have identical or distinct target specificity. For this purpose, 
15 in vitro established cell lines were randomly selected because of their availa- 
bility in the laboratory and used as target cells in the NK assays. One previously 
described clone,  termed JT3,  was used as a  control in these experiments.  As 
shown in Table IV, JT9 and JT10 cells were found to display a superimposable 
pattern of reactivity towards the panel of cell lines tested. Results obtained in 
these assays were rather clearcut. Indeed, specific cytotoxicity of  JT9 and JT10 
cells ranged from 45 to  100% for one group of target cells,  but was <10%  for 
the other. The reactivity of the JT3  clone was distinct from that of JT9  and 
JT 10 since, for example, JT3 cells did not exhibit significant lysis for target cells 
such as Nalm-1. 
JT9 Cells Do Not Interact with Target Cells Via Recognition of Class I or Class II 
Products of the Major Histocompatibility Complex (MHC) Region.  The experiments 
reported  above  strongly suggested that JT9  and JT10  cells  use  a  T3-90  kD HERCEND  ET  AL. 
TABLE  IV 
Cytolytic Activity of  JT  3, JT9, and JT I O Cloned Cells 
1555 
Effector cells  Targets 
K562  KG-1  U937  HL60  Daudi  Laz 221  Nalm-1  Laz 461 
JT3*  +*  +/-  +/-  -  +  +/-  -  - 
JT9  +  +  +  -  +  +  +  - 
JT10  +  +  +  -  +  +  +  - 
Laz 156  Laz 388  Molt 4  HSB  HPB-ALL  JM  CEM 
JT3*  -  -  +  +  +/-  +  +/- 
JT9  -  -  +  +  +  +  + 
JT10  -  -  +  +  +  +  + 
* Results are representative of at least three individual experiments for each clone. 
* Specific cytotoxicity: +, >45%; +/-, <45%; -, <10%. E/T ratio,  10:1. 
TABLE  V 
Influence of Anti-HLA and Anti-la Antisera on Effector Functions of Clone JT9, 
CT8m, and CT4u 
Percent specific lysis 
Antiserum  Effector clone:  JT9  CT8n,  CT4n 
Target:  K562  Molt-4  Laz 221  Laz 156  Laz 156 
Medium  81 *  75  66  72  38 
w6/32'  89  81  79  22  39 
Anti-p29/34  !  90  73  70  66  3 
* Standard deviation,  <15%. 
* Monoclonal antibody specific for HLA (class I). 
Rabbit heteroantisera specific for human Ia antigens (class II). 
complex as well as specific CTL  to interact  with target cells.  However, JT9  and 
JT 10  clones  were  selected  after  nonspecific  mitogen  stimulation  and  display  a 
broad  reactivity  against  genetically  unrelated  tumor  cells.  Since  both JT9  and 
JT 10 also express T3, T8, and T11  antigens,  they consequently appear to be an 
additional  population  of CTL  clearly distinct from the previously characterized 
alioreactive  (or self-modified  reactive)  CTL.  To  substantiate  this point,  experi- 
ments were conducted to investigate whether JT9  cells would, like CTL, interact 
with targets via recognition of either class I or II products of the MHC. For this 
purpose,  three representative  target cell lines,  K562,  Molt-4, and Laz 221  were 
used  in  the  experiments.  K562  cells  do  not  express  either  class  I  or  class  II 
antigens whereas Molt-4 cells express class I but not class II antigens.  In contrast, 
both  Ia  and  HLA  structures  are  present  on  Laz  221  cells.  CT8m  and  CT4lb 
which  are  well-characterized  human  CTL  clones  directed  at  Laz  156  EBV- 
transformed B cells, were used as controls in these assays (19). As shown in Table 
V,  it was found that preincubation  of the  three  NK target  cells with anti-HLA 
or anti-Ia antibodies  did not affect subsequent  lysis by JT9  cells.  In contrast,  as 
previously  reported,  preincubation  of Laz  156  cells  with  anti-class  I  antibody 
resulted  in  a  marked  decrease  of cytotoxicity  mediated  by  CT8m.  Similarly, 1556  ANTIBODY  BLOCKING  NATURAL KILLING 
preincubation  of Laz  156 cells with anti-class  II antibody was only effective in 
inhibiting cytotoxicity mediated by CT4H cells. 
Discussion 
A series of monoclonal antibodies termed anti-Ti have recently been produced 
using antigen-specific  CTL  clones for immunization.  The  target  structures  of 
these reagents  were identified  as clonally restricted  90  kD heterodimers.  The 
anti-Ti  antibodies  were  shown  to  block antigen-specific  proliferation  of CTL 
clones as well as cytotoxicity against antigen-bearing target cells. These functional 
effects strongly suggested that 90 kD clonotypic determinants represent antigen- 
receptor structures on specific T  lymphocytes (15, 23). 
In  the  present  studies,  mice  were immunized  with JT9  cloned  cells,  which 
represent  NK active lymphocytes expressing  a  mature  T  cell phenotype (T1 + 
T3 + T8 + T 11 + T 12+). These experiments were conducted to obtain monoclonal 
antibodies  directed  at  cell  surface  structures  involved  in  cytotoxic  reactions 
performed  by JT9  cells.  One  monoclonal  antibody,  termed  anti-NKTa,  was 
selected because of its capacity to block the cytotoxicity of JT9  towards K562 
cells. Immunoprecipitation procedures indicated that anti-NKTa was directed at 
a  heterodimer  of identical  90 kD molecular mass as the anti-Ti  antibodies.  In 
addition,  anti-NKTa  was shown  to  have  functional  effects that  are  strikingly 
similar to those produced by anti-Ti.  Namely, both anti-NKTa and anti-Ti block 
cytotoxic function and increase proliferative response to IL-2 of respective clones. 
Moreover, NKTa and T3 structures were found to co-modulate after interaction 
with  corresponding  antibodies.  Such  a  linkage  to  the  T3  molecule  has  been 
shown to represent a major characteristic of the Ti determinants (15, 23). 
The identification of a  90 kD heterodimer on JT9 and JT 10 cells represents 
a  major step in the characterization  of these clones. It indicates that  NK active 
mature T  lymphocytes are very closely related to specific CTL that have previ- 
ously been shown to use a 90 kD-T3 molecular complex to interact with specific 
targets  (15,  23).  Nevertheless,  JT9  and  JT10  cells  are  representative  of a 
population of T  lymphocytes that is clearly distinct from previously characterized 
ailoreactive or self-modified reactive cytotoxic T  cells. NK active clones such as 
JT9 and JT10 were obtained after nonspecific mitogen stimulation  (8,  14) and 
can kill  a  variety of unrelated  target  cells. Perhaps more importantly, JT9 and 
JT 10 cells are cytotoxic for cells such as K562, that do not express HLA antigens, 
or Molt-4, that do not express Ia antigens.  In addition,  their cytotoxicity is not 
blocked by preincubation of representative target cells with either anti-class I or 
anti-class II antibodies. These findings are distinct from those obtained with the 
great majority of alloreactive CTL clones. Indeed, in the latter case, it has been 
found that T4 + alloreactive CTL specifically interact with targets via recognition 
of class II antigens (19, 24) and that T8 + alloreactive CTL interact with targets 
via recognition  of class  I  antigens  (19).  The  absence of genetic restriction  for 
class I or class II products of the MHC complex appears to be a unique functional 
characteristic of mature T  lymphocytes that have NK activity. 
Based upon the fact that cytotoxicity of the great majority of T8 + alioreactive 
CTL could be blocked by either anti-HLA antibodies at the target cell level or 
anti-T8  antibodies at the effector cell level, it has been postulated that  the T8 HERCEND  ET  AL.  1557 
molecule represents  an  associative  recognition  structure  for a  monomorphic 
region of class I antigens (25). In this context, the absence of blocking effects of 
anti-T8 antibodies on the cytotoxicity of  JT9 cells correlates well with the absence 
of genetic restriction of these cells for class I antigens. 
In contrast to anti-Ti antibodies available thus far, anti-NKTa antibody was 
found to react with two clones (JT9, JT10) and not only with the immunizing 
cells (JT9). Given the fact that individual NK clones can have different target 
specificities (14), it was of great interest to compare the specificity of JT9 and 
JT10 cells that express the identical 90 kD clonotype. It was found that JT9 and 
JT 10 cells had a superimposable pattern of reactivity towards 15 different target 
cells tested. Although these results do not constitute a direct demonstration, they 
suggest that the NKTa structure is responsible for the target specificity of JT9 
and JT10  NK  active  cells and  is  therefore functionally analogous  to  the  Ti 
determinants present on alloreactive T  cell clones. In addition, it is important to 
point out that NKTa-positive clones did not react with anti-Ti antibodies (data 
not shown) and, conversely, Ti-bearing clones did not react with anti-NKTa. 
This suggests that the NKTa determinant represents a variable region of the 90 
kD  heterodimer. Furthermore, two individual  lines, JT9  and JT10,  out of a 
relatively small  number  of NK  clones  tested,  were  found  to  express  NKTa 
whereas only 1 out of 80 CTL clones directed against the same EBV-transformed 
B cell line, Laz 156, reacted with anti-TilA and anti-Ti~B (15). Although additional 
studies need to be performed to substantiate this point, these results suggest a 
much lox4er  degree of diversity within  the NK  effector population  than  that 
found fc,  r alloreactive cytotoxic T  cells. 
Taken together, the data presented here leads to a  working hypothesis con- 
cerning the nature of one population  of "NK-active" lymphocytes represented 
by JT9 and JT10  cells. These cloned cells are mature T  lymphocytes because 
they express the T3  structure that is involved in expression of their cytotoxic 
function. Although the NK active clones display a broad reactivity, they do have 
target specificity since, for example, they do not spontaneously kill EBV-trans- 
formed B cell lines, whereas strong cytotoxicity against these targets is obtained 
after lectin approximation (unpublished data). Furthermore, they express unique 
90  kD heterodimeric determinants that are functionally linked to T3  antigen 
and which may represent the structural basis for their specificity. 
The present studies support the view that at least one population of lympho- 
cytes that mediate NK or NK-like activity may, in fact, represent an additional 
subset of mature "specific" T  cells. The target antigen of these specific T  cells is 
unknown at the present time. However, given the broad cellular reactivity of the 
NK clones, this antigen must have a relatively wide but yet restricted distribution 
on in vitro established cell lines commonly used in NK assays. In addition, this 
antigen does not appear to be recognized in association with either class  I  or 
class  II products of the MHC complex. Identification of the target antigen of 
JT9 and JT 10 cells will, of course, represent one of the goals for further studies. 
Perhaps more importantly, the nature of the other populations of human NK 
cells will be investigated in light of the present results. For this purpose, clones 
such as JT3  (14) that express T11  but not T3 structures or clones such as JT1 
(7,  14) that do not express any presently identified T  cell-associated molecules, 1558  ANTIBODY BLOCKING NATURAL KILLING 
represent  valuable  tools.  In  future  studies,  it  will  be  necessary  to  determine 
whether the specificity of these other types of NK clones is also associated with 
90 kD structures or with different surface molecules.  Hopefully, this approach 
will  lead to a  better understanding  of the diversity of NK cells and  ultimately 
help to clarify their biological significance. 
Summary 
The present studies were carried out to identify surface molecules involved in 
the cytotoxic effector function of a human natural killer (NK) clone termedJT9. 
This clone represents a mature T  lymphocyte (T3+T8+T 11 +) mediating NK-like 
activity.  Using JT9  for  immunization,  one  monoclonal  antibody  termed  anti- 
NKTa was selected that blocked the cytotoxicity of the clone towards K562 cells. 
Reactivity of anti-NKTa antibody was assessed using a  large panel of lymphoid 
and nonlymphoid cells including a variety of cloned cell lines with either cytotoxic 
T  lymphocyte  (CTL)  or  NK-like  activity.  Among  all  cells  tested,  only  two 
individual  clones, JT9 and JT10,  were found to express NKTa antigen. JT10 
was derived independently from the same individual as JT9 and also represents 
a mature T  cell (T3+T8+T 11 +) mediating NK-like activity. Like the Ti structure 
on CTL clones, the molecule defined by anti-NKTa was shown to be membrane 
associated with T3 in co-modulation experiments. Moreover, anti-NKTa precip- 
itated a 90 kD heterodimeric structure in sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis analysis of 1~5I surface-labeled JT9 cells. 
The blocking capacity of anti-NKTa was evaluated in cytotoxicity assays using 
a panel of target cells. The influence of anti-T3 was tested in parallel and it was 
found that both anti-NKTa and anti-T3  blocked the cytotoxicity of the cloned 
cells against all targets.  Given the potential role of 90 kD molecules as antigen- 
receptor structures,  the specificity of the two NKTa ÷ NK clones was compared 
and found superimposable when assessed using  15 in vitro established cell lines. 
However, in contrast to conventional CTL clones, the expression of cytotoxicity 
byJT9 andJT10 was not dependent upon recognition of class I or class II major 
histocompatibility complex gene products  on the  target  cells.  In addition,  the 
cytotoxicity of these  T8 ÷  NK  active  clones  could  not  be  blocked by anti-T8 
antibodies.  Taken together,  the present data suggest that the specificity of one 
population of human  NK active lymphocytes is determined by clonotypic struc- 
tures.  The  NKTa  determinant  identified  here  appears  to belong to the  same 
family of molecules as Ti structures, previously identified on antigen-specific T 
lymphocytes. 
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